Tocolysis in Placenta Previa

ABDUL-KARIM R.W. , CHEVLI R.N. Antepartum hemorrhage and shock. Clin Obstet Gynecol 1976; 19: 533–59.

SILVER R. , DEPP R. , SABBAGHA R.E. , DOOLEY S.L. , SOCOL M.L. , TAMURA R.K. Placenta previa: aggressive expectant management. Am J Obstet Gynecol 1984; 150: 15–22.

MCSHANE P.M. , HEYL P.S. , EPSTEIN M.F. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol 1985; 65: 176–82.

SAUER M. , PARSONS M. , SAMPSON M. Placenta previa: an analysis of three years of experience. Am J Perinatol 1985; 2: 39–42.

PRITCHARD J.A. , MACDONALD P.C. , GANT N.F. , eds. Williams' obstetrics. 7th ed. Norwalk, CT: Appleton-Century-Crofts, 1985: 389–421.

FUCHS F. Endocrinology of parturition. In: Fuchs F. , Klopper A. , eds. Endocrinology of pregnancy. 3rd ed. Philadelphia: Lippincott-Harper and Row, 1983: 247–70.

MOSLER K.H. , LINKA F. , DORNHOFER W. , EHRHART J. Tocolytic therapy in obstetrics. J Perinatol Med 1974; 2: 3–16.

RALL T.W. , SHLEIFER L.S. Oxytocin, prostaglandins, ergot alkaloids, and other drugs; tocolytic agents. In: Goodman L.S. , Gilman A.G. , Rall T.W. , Murad F. , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985: 942–3.

LAMPE K. , ed. AMA drug evaluations. 6th ed. Chicago: American Medical Association, 1986: 821–4.

FORMAN A. , ANDERSSON K. , MAIGAARD S. Effects of calcium channel blockers on the female genital tract. Acta Pharmacol Toxicol [Copenhagen] 1986; 58(suppl 2): 183–92.

FUCHS A. , FUCHS F. Mechanism and prevention of preterm birth. Prog Clin Biol Res 1985; 163B: 223–30.

NIEBYL J.R. , BLAKE D.A. , WHITE R.D. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980; 136: 1014–9.

BEALL M.H. , EDGAR B.W. , PAUL R.H. , SMITH-WALLACE T. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol 1985; 153: 854–9.

HOLLANDER D.I. , NAGEY D.A. , PUPKIN M.J. Magnesium sulfate and ritodrine hydrochloride: a randomized comparison. Am J Obstet Gynecol 1987; 156: 631–7.

STEER C.M. , PETRIE R.H. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977; 129: 1–4.

COTTON D.B. , READ J.A. , PAUL R.H. , QUILLIGAN E.J. The conservative aggressive management of placenta previa. Am J Obstet Gynecol 1980; 137: 687–95.

HASTWELL G. , LAMBERT B.E. A comparison of salbutamol and ritodrine when used to inhibit premature labour complicated by ante-partum haemorrhage. Curr Med Res Opin 1979; 5: 785–9.

FLOWERS W.K. Ritodrine use in placenta previa. J Nat Med Assoc 1983; 75: 427–8.

NAKAMURA Y. , NOMURA Y. , SHINAGAWA S. Clinical usefulness of terbutaline in the management of placenta praevia. Acta Obstet Gynaecol Jpn 1984; 36: 947–9.

SAMPSON M.B. , LATRES O. , TOMASI A.M. , THOMASON J.L. , WORK B.A. Tocolysis with terbutaline sulfate in patients with placenta previa complicated by premature labor. J Reprod Med 1984; 29: 248–50.

TOMICH P.G. Prolonged use of tocolytic agents in the expectant management of placenta previa. J Reprod Med 1985; 30: 745–8.

BENEDETTI T.J. Maternal complications of parenteral beta-sympathomimetic therapy for premature labor. Am J Obstet Gynecol 1983; 145: 1–6.

WEINER N. Norepinephrine, epinephrine, and the sympathomimetic amines. In: Goodman L.S. , Gilman A.G. , Rall T.W. , Murad F. , eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed. New York: Macmillan, 1985: 145–80. Vitamin E in Children with Chronic Cholestasis